GAMAMABS Trademark

Trademark Overview


On Tuesday, December 1, 2015, a trademark application was filed for GAMAMABS with the United States Patent and Trademark Office. The USPTO has given the GAMAMABS trademark a serial number of 86835146. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2019. This trademark is owned by GamaMabs Pharma SA. The GAMAMABS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancers and pharmaceutical preparations for the treatment of other proliferative diseases, namely, pharmaceuticals for the treatment of endometriosis, pharmaceuticals for the treatment of Polycystic Ovary Syndrome and pharmaceuticals for the treatment of tubal disease; monoclonal antibodies for the treatment of cancers and monoclonal antibodies for the treatment of other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, gene expression profiles or other molecular indicators or markers, namely, nucleic acid sequences and chemical reagents for medical purposes

Drug delivery devices, namely, drug delivery systems; injection devices for pharmaceutical preparations for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease; diagnostic devices, namely, biosensor analyzers for detecting cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, medical imaging apparatus for diagnosing cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, immunoanalyzers, namely, immunochemical testing equipment for medical use; medical testing equipment in the nature of medical instruments for analyzing and identifying bacteria in the nature of bacteriologic analyzers, for manual or for automated analysis for use in measuring or testing of biological samples in medical and clinical applications for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycysti...

Chemical, biological and pharmaceutical research and development in the field of cancers and other proliferative diseases; conducting clinical trials for others in the field of cancers and other proliferative diseases
gamamabs

General Information


Serial Number86835146
Word MarkGAMAMABS
Filing DateTuesday, December 1, 2015
Status700 - REGISTERED
Status DateTuesday, October 8, 2019
Registration Number5876999
Registration DateTuesday, October 8, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancers and pharmaceutical preparations for the treatment of other proliferative diseases, namely, pharmaceuticals for the treatment of endometriosis, pharmaceuticals for the treatment of Polycystic Ovary Syndrome and pharmaceuticals for the treatment of tubal disease; monoclonal antibodies for the treatment of cancers and monoclonal antibodies for the treatment of other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, gene expression profiles or other molecular indicators or markers, namely, nucleic acid sequences and chemical reagents for medical purposes
Pseudo MarkGAMA ABS
Goods and ServicesDrug delivery devices, namely, drug delivery systems; injection devices for pharmaceutical preparations for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease; diagnostic devices, namely, biosensor analyzers for detecting cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, medical imaging apparatus for diagnosing cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, immunoanalyzers, namely, immunochemical testing equipment for medical use; medical testing equipment in the nature of medical instruments for analyzing and identifying bacteria in the nature of bacteriologic analyzers, for manual or for automated analysis for use in measuring or testing of biological samples in medical and clinical applications for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease
Goods and ServicesChemical, biological and pharmaceutical research and development in the field of cancers and other proliferative diseases; conducting clinical trials for others in the field of cancers and other proliferative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 4, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, December 4, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 4, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGamaMabs Pharma SA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToulouse Cedex 1 BP50624
FR

Party NameGamaMabs Pharma SA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToulouse Cedex 1 BP50624
FR

Party NameGamaMabs Pharma SA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToulouse Cedex 1 BP50624
FR

Trademark Events


Event DateEvent Description
Wednesday, March 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, March 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 19, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 18, 2019CASE RETURNED TO EXAMINATION
Friday, June 14, 2019NOTICE OF ALLOWANCE CANCELLED
Friday, June 14, 2019PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, June 14, 2019ASSIGNED TO PETITION STAFF
Friday, May 17, 2019TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, December 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 17, 2018EXTENSION 2 GRANTED
Monday, December 17, 2018EXTENSION 2 FILED
Monday, December 17, 2018TEAS EXTENSION RECEIVED
Friday, June 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 13, 2018EXTENSION 1 GRANTED
Wednesday, June 13, 2018EXTENSION 1 FILED
Wednesday, June 13, 2018TEAS EXTENSION RECEIVED
Tuesday, January 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 29, 2017EXPARTE APPEAL TERMINATED
Friday, September 29, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 28, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, September 28, 2017ASSIGNED TO LIE
Thursday, September 28, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 28, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, September 28, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 26, 2017NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, September 26, 2017SUBSEQUENT FINAL EMAILED
Tuesday, September 26, 2017SUBSEQUENT FINAL REFUSAL WRITTEN
Tuesday, September 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 21, 2017NON-FINAL ACTION E-MAILED
Tuesday, March 21, 2017NON-FINAL ACTION WRITTEN
Thursday, March 2, 2017EX PARTE APPEAL-INSTITUTED
Thursday, March 2, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, March 2, 2017EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, February 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 28, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 28, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, September 2, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, September 2, 2016FINAL REFUSAL E-MAILED
Friday, September 2, 2016FINAL REFUSAL WRITTEN
Wednesday, August 31, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 30, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 30, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 21, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 21, 2016NON-FINAL ACTION E-MAILED
Monday, March 21, 2016NON-FINAL ACTION WRITTEN
Sunday, March 20, 2016ASSIGNED TO EXAMINER
Saturday, December 5, 2015NOTICE OF PSEUDO MARK E-MAILED
Friday, December 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 4, 2015NEW APPLICATION ENTERED IN TRAM